CJC 1295 10mg
All peptide vials are supplied in sterile lyophilized powder form (except bacteriostatic diluents) and are strictly for laboratory investigation.
Modified GRF (1-29) CJC-1295 without DAC (10mg) lyophilized research peptide for in-vitro signaling studies.
Pricing and ordering are restricted to verified account holders (21+). Sign in or create a free researcher account to view pricing and place orders.
Sign In / Create Account →All products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Prime Labs is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Prime Labs is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.
Description
Modified GRF (1-29) CJC-1295 without DAC (10mg) lyophilized research peptide for in-vitro signaling studies.
Laboratory Specifications
- Compound: CJC 1295 10mg
- SKU: PL-CJC-10
- Purity: ≥99% (HPLC Verified)
- Form: Sterile Filtered, Lyophilized / Sealed Research Vial
- Application: Strictly for In-Vitro Laboratory Research & Development Use Only
🧊 Product Care & Storage
Store refrigerated at 2°C–8°C (36°F–46°F) or frozen at -20°C in lyophilized state. Follow your institutional standard operating procedures (SOPs) for handling research compounds.
🔬 Product Note (Research Use Only · No Dosing Guidance)
All peptide reference materials are shipped in lyophilized (powder) form and must be handled exclusively within qualified laboratory environments. We are unable to provide any reconstitution, clinical, or dosing instructions. All products are strictly for in-vitro scientific research use only.
📊 Analytical Summary (PL-CJC-10)
- CAS Number: 863288-34-0 (Mod GRF 1-29)
- Molecular Weight: 3367.97 Da (g/mol)
- Molecular Formula: C152H252N44O42
- Vial Presentation: 3mL USP Type I Borosilicate Vial (10mg)
- Assay Purity: ≥99.3% (RP-HPLC)
Analytical & Chemical Specifications
| Compound Designation | Modified GRF (1-29) Tetrasubstituted 29-AA Peptide (Without DAC) |
|---|---|
| Catalog SKU | PL-CJC-10 |
| Size / Strength | 10mg |
| Form | Lyophilized Powder (Sterile Filtered) |
| Vial Size | 3mL USP Type I Borosilicate Vial |
| CAS Registry Number | 863288-34-0 (Mod GRF 1-29) |
| Molecular Formula | C152H252N44O42 |
| Molecular Weight | 3367.97 Da (g/mol) |
| Purity Standard | ≥99.3% (RP-HPLC) |
| Sequence / Composition | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 |
| Reference Lot # | PL-2609-CJC10 (09/2026) |
| Storage Protocol | Store refrigerated at 2°C–8°C (36°F–46°F) or frozen at -20°C in lyophilized state. |
| Terms of Supply | Strictly for In-Vitro Laboratory Research Use Only (RUO). Not for human or veterinary use. |
Verified orders placed before 12:00 PM EST (M–F) are processed and dispatched the same business day.
Multiple tracked U.S. shipping options with protective borosilicate vial packaging.
Disciplined analytical protocols built on RP-HPLC purity, ESI-MS identity, and LAL endotoxin screening.
Dedicated researcher assistance for batch COAs, institutional accounts, and order tracking.
The Standard of Excellence
At every step, Prime Labs prioritizes reproducibility by conducting rigorous third-party testing on our catalog. These analytical assays focus on four key characteristics—identity, purity (≥99%), sterility, and endotoxicity—ensuring that each batch meets strict laboratory reference standards backed by independent Certificates of Analysis (COAs).
